The National Institute of Nursing Research (NINR) and National Cancer Institute (NCI) are offering an Exploratory/Developmental (R21) grant. This grant is for stimulating research on clinical decision-making processes for individuals at risk for or faced with life-threatening illnesses. It supports studies on choices from adopting preventive behaviors through end-of-life care. Examples include decisions about HIV vaccine trials, genetic testing, selecting treatment interventions versus watchful waiting, choosing among multiple treatment options, joining therapeutic clinical trials, or making end-of-life care decisions. This opportunity aims to enhance understanding of critical health choices.
Opportunity ID: 46070
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-09-121 |
| Funding Opportunity Title: | Research on Clinical Decision Making in People with or at Risk for Life-Threatening Illness (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.361 — Nursing Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 17, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2012 |
| Current Closing Date for Applications: | May 07, 2012 |
| Archive Date: | Jun 07, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments State governments Special district governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. This funding opportunity announcement (FOA) issued by the National Institute of Nursing Research (NINR) and the National Cancer Institute (NCI), National Institutes of Health, seeks to stimulate research on the decision-making processes made by persons at risk for and those faced with life-threatening illness. These illnesses are ones that almost always lead to death in a fairly short period of time if left untreated, but may be chronic or even cured if dealt with early in the disease process. An example of a life-threatening illness that may be chronic for some years would be HIV infection when treated. An example of a life-threatening illness that may be cured in its early stages would be breast cancer. Decision-making can occur from the point of adopting preventive behaviors through the end of life. Examples of such decisions could include participating in an HIV vaccine clinical trial, testing for genetic disorder, choosing a treatment intervention vs. watchful waiting (as in early stage prostate cancer), choosing a treatment intervention among several options, joining a therapeutic clinical trial, or making end-of-life care decisions. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-09-122, that encourages applications under the R01 mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism, numbers, quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-09-121.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-A | Adobe-Forms-A | PKG00011101 | May 16, 2009 | Feb 20, 2010 | View | |
| ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00015353 | Dec 21, 2009 | Nov 02, 2010 | View | |
| ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00022274 | Nov 02, 2010 | May 07, 2012 | View |
Package 1
Mandatory forms
46070 RR_SF424-1.1.pdf
46070 RR_KeyPersonExpanded-1.1.pdf
46070 RR_OtherProjectInfo-1.1.pdf
46070 RR_PerformanceSite-1.1.pdf
46070 PHS398_CoverPageSupplement-1.1.pdf
46070 PHS398_ResearchPlan-1.1.pdf
46070 PHS398_Checklist-1.1.pdf
Optional forms
46070 PHS398_CoverLetter-1.1.pdf
46070 PHS398_ModularBudget-1.1.pdf
46070 RR_Budget-1.1.pdf
46070 RR_SubawardBudget-1.2.pdf
Package 2
Mandatory forms
46070 RR_SF424_1_2-1.2.pdf
46070 PerformanceSite_1_3-1.3.pdf
46070 RR_OtherProjectInfo_1_2-1.2.pdf
46070 RR_KeyPersonExpanded_1_2-1.2.pdf
46070 PHS398_CoverPageSupplement_1_4-1.4.pdf
46070 PHS398_ResearchPlan_1_3-1.3.pdf
46070 PHS398_Checklist_1_3-1.3.pdf
Optional forms
46070 PHS_CoverLetter_1_2-1.2.pdf
46070 PHS398_ModularBudget-1.1.pdf
46070 RR_Budget-1.1.pdf
46070 RR_SubawardBudget-1.2.pdf
Package 3
Mandatory forms
46070 RR_SF424_1_2-1.2.pdf
46070 RR_OtherProjectInfo_1_3-1.3.pdf
46070 RR_KeyPersonExpanded_1_2-1.2.pdf
46070 PerformanceSite_1_4-1.4.pdf
46070 PHS398_ResearchPlan_1_3-1.3.pdf
46070 PHS398_CoverPageSupplement_1_4-1.4.pdf
46070 PHS398_Checklist_1_3-1.3.pdf
Optional forms
46070 RR_Budget-1.1.pdf
46070 RR_SubawardBudget-1.2.pdf
46070 PHS_CoverLetter_1_2-1.2.pdf
46070 PHS398_ModularBudget-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
